PATRONO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 3.287
AS - Asia 2.294
EU - Europa 2.040
SA - Sud America 164
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 7.822
Nazione #
US - Stati Uniti d'America 3.228
SG - Singapore 880
CN - Cina 651
UA - Ucraina 370
IE - Irlanda 312
TR - Turchia 300
SE - Svezia 259
RU - Federazione Russa 246
GB - Regno Unito 226
DE - Germania 179
VN - Vietnam 176
FR - Francia 168
BR - Brasile 135
IT - Italia 131
IN - India 111
FI - Finlandia 91
BD - Bangladesh 57
HK - Hong Kong 28
CA - Canada 23
MX - Messico 22
IQ - Iraq 16
AR - Argentina 14
PL - Polonia 14
ZA - Sudafrica 14
NL - Olanda 10
IL - Israele 9
JP - Giappone 9
ID - Indonesia 8
BE - Belgio 7
SA - Arabia Saudita 7
AT - Austria 5
CZ - Repubblica Ceca 5
EG - Egitto 5
ES - Italia 5
EU - Europa 5
JM - Giamaica 5
PH - Filippine 5
UY - Uruguay 5
IR - Iran 4
KR - Corea 4
PK - Pakistan 4
TW - Taiwan 4
VE - Venezuela 4
CL - Cile 3
DZ - Algeria 3
HN - Honduras 3
JO - Giordania 3
MA - Marocco 3
AU - Australia 2
BB - Barbados 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 7.822
Città #
Singapore 660
Jacksonville 411
San Jose 410
Chandler 365
Dublin 310
Ashburn 198
Beijing 189
Southend 172
Izmir 147
Princeton 143
Dallas 128
Wilmington 105
Nanjing 102
Santa Clara 91
Los Angeles 88
Dearborn 75
Cambridge 67
Ho Chi Minh City 53
Buffalo 46
New York 46
Munich 44
Council Bluffs 42
The Dalles 42
Ann Arbor 41
Tongling 39
Hanoi 38
Nanchang 36
Moscow 35
Woodbridge 35
Altamura 29
Hong Kong 26
Shenyang 23
Kunming 21
Helsinki 19
Boardman 18
Jiaxing 18
Grevenbroich 17
Hebei 17
Houston 17
São Paulo 16
Washington 16
Changsha 15
Augusta 14
Hefei 13
Norwalk 13
Brooklyn 12
Chieti 12
Orem 12
Redondo Beach 12
Tianjin 12
Johannesburg 11
Warsaw 11
Haiphong 10
Hangzhou 10
San Mateo 10
Boston 9
Chicago 9
Da Nang 9
Falls Church 9
Frankfurt am Main 9
Tokyo 9
Baghdad 8
Chennai 8
Lanzhou 8
Montreal 8
Orange 8
Seattle 8
Atlanta 7
Brussels 7
Jinan 7
Leawood 7
Phoenix 7
Shanghai 7
Lucca 6
Poplar 6
Queens 6
Querétaro 6
Rome 6
San Francisco 6
Stockholm 6
Toronto 6
Amsterdam 5
Belo Horizonte 5
Denver 5
Manchester 5
Mexico City 5
Milan 5
Turku 5
Zhengzhou 5
Brno 4
Hackney 4
Hải Dương 4
Kingston 4
Montevideo 4
Nha Trang 4
Padua 4
Seoul 4
Taiyuan 4
Tavagnacco 4
Bandung 3
Totale 4.837
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 184
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 173
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 163
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 163
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 154
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 151
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 143
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 141
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 137
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 134
Insulin resistance as a determinant of platelet activation in obese women. 132
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 131
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 128
Determinants of platelet activation in human essential hypertension. 127
Increased thromboxane biosynthesis in essential thrombocythemia 126
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 126
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 124
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 124
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 124
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 123
Aspirin, platelet inhibition and cancer prevention. 123
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 121
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 121
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 120
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 119
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 119
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 116
Drugs, prostaglandins, and renal function. 115
Determinants of platelet activation in Alzheimer's disease 115
Role of Platelet Activation in Dementia 114
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 114
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 113
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 113
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 113
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 112
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 112
Effects of nabumetone on prostanoid biosynthesis in humans. 111
Insulin resistance as a determinant of platelet activation in obese women 110
Antiplatelet agents in the prevention of diabetic vascular complications 110
Mechanisms, consequences, and prevention of coronary graft failure 108
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 107
Platelet activation in obese women: role of inflammation and oxidant stress. 106
Determinants of Platelet Activation in Heart Failure. 106
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 105
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 105
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 105
Nutraceuticals in diabetes and metabolic syndrome. 103
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 103
Cyclooxygenase-2 expression and inhibition in human monocytes 102
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 100
Determinants of Platelet Activation in Heart Failure. 97
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 96
Soluble CD40L as an indicator of platelet Activation in Heart Failure 96
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 94
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 93
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 93
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 91
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 91
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 88
Insulin resistance as a determinant of platelet activation in obese women 88
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 87
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 87
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 85
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 84
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 81
Thromboxane biosynthesis in cardiovascular diseases 78
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 77
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 76
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 71
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 68
In vivo platelet activation in diabetes mellitus 56
Off-pump coronary artery bypass grafting: 30 years of debate 48
Platelet activation, aspirin, and cancer: From basic science to clinical trials 6
Totale 7.980
Categoria #
all - tutte 31.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 0 20
2021/2022275 1 4 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/20251.184 95 283 202 16 9 41 12 29 79 41 128 249
2025/20262.516 236 114 222 261 288 155 468 100 286 201 130 55
Totale 7.980